Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond W Colburn

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010
Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.
Experimental Neurology|April 23, 2015
Large animal and primate models of spinal cord injury for the testing of novel therapiesBrian K Kwon, Femke Streijger, Caitlin E Hill, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010
Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.
Experimental Neurology|April 23, 2015
Large animal and primate models of spinal cord injury for the testing of novel therapiesBrian K Kwon, Femke Streijger, Caitlin E Hill, et al.
Pageof 2